首页 > 最新文献

JMIR dermatology最新文献

英文 中文
The Comparative Sufficiency of ChatGPT, Google Bard, and Bing AI in Answering Diagnosis, Treatment, and Prognosis Questions About Common Dermatological Diagnoses.
Q3 Medicine Pub Date : 2025-01-07 DOI: 10.2196/60827
Courtney A Chau, Hao Feng, Gabriela Cobos, Joyce Park

Unlabelled: Our team explored the utility of unpaid versions of 3 artificial intelligence chatbots in offering patient-facing responses to questions about 5 common dermatological diagnoses, and highlighted the strengths and limitations of different artificial intelligence chatbots, while demonstrating how chatbots presented the most potential in tandem with dermatologists' diagnosis.

{"title":"The Comparative Sufficiency of ChatGPT, Google Bard, and Bing AI in Answering Diagnosis, Treatment, and Prognosis Questions About Common Dermatological Diagnoses.","authors":"Courtney A Chau, Hao Feng, Gabriela Cobos, Joyce Park","doi":"10.2196/60827","DOIUrl":"https://doi.org/10.2196/60827","url":null,"abstract":"<p><strong>Unlabelled: </strong>Our team explored the utility of unpaid versions of 3 artificial intelligence chatbots in offering patient-facing responses to questions about 5 common dermatological diagnoses, and highlighted the strengths and limitations of different artificial intelligence chatbots, while demonstrating how chatbots presented the most potential in tandem with dermatologists' diagnosis.</p>","PeriodicalId":73553,"journal":{"name":"JMIR dermatology","volume":"8 ","pages":"e60827"},"PeriodicalIF":0.0,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Depth Estimation and Visualization of Dermatological Lesions: Development and Usability Study.
Q3 Medicine Pub Date : 2024-12-18 DOI: 10.2196/59839
Pranav Parekh, Richard Oyeleke, Tejas Vishwanath
<p><strong>Background: </strong>Thus far, considerable research has been focused on classifying a lesion as benign or malignant. However, there is a requirement for quick depth estimation of a lesion for the accurate clinical staging of the lesion. The lesion could be malignant and quickly grow beneath the skin. While biopsy slides provide clear information on lesion depth, it is an emerging domain to find quick and noninvasive methods to estimate depth, particularly based on 2D images.</p><p><strong>Objective: </strong>This study proposes a novel methodology for the depth estimation and visualization of skin lesions. Current diagnostic methods are approximate in determining how much a lesion may have proliferated within the skin. Using color gradients and depth maps, this method will give us a definite estimate and visualization procedure for lesions and other skin issues. We aim to generate 3D holograms of the lesion depth such that dermatologists can better diagnose melanoma.</p><p><strong>Methods: </strong>We started by performing classification using a convolutional neural network (CNN), followed by using explainable artificial intelligence to localize the image features responsible for the CNN output. We used the gradient class activation map approach to perform localization of the lesion from the rest of the image. We applied computer graphics for depth estimation and developing the 3D structure of the lesion. We used the depth from defocus method for depth estimation from single images and Gabor filters for volumetric representation of the depth map. Our novel method, called red spot analysis, measures the degree of infection based on how a conical hologram is constructed. We collaborated with a dermatologist to analyze the 3D hologram output and received feedback on how this method can be introduced to clinical implementation.</p><p><strong>Results: </strong>The neural model plus the explainable artificial intelligence algorithm achieved an accuracy of 86% in classifying the lesions correctly as benign or malignant. For the entire pipeline, we mapped the benign and malignant cases to their conical representations. We received exceedingly positive feedback while pitching this idea at the King Edward Memorial Institute in India. Dermatologists considered this a potentially useful tool in the depth estimation of lesions. We received a number of ideas for evaluating the technique before it can be introduced to the clinical scene.</p><p><strong>Conclusions: </strong>When we map the CNN outputs (benign or malignant) to the corresponding hologram, we observe that a malignant lesion has a higher concentration of red spots (infection) in the upper and deeper portions of the skin, and that the malignant cases have deeper conical sections when compared with the benign cases. This proves that the qualitative results map with the initial classification performed by the neural model. The positive feedback provided by the dermatologist suggests that th
{"title":"The Depth Estimation and Visualization of Dermatological Lesions: Development and Usability Study.","authors":"Pranav Parekh, Richard Oyeleke, Tejas Vishwanath","doi":"10.2196/59839","DOIUrl":"10.2196/59839","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Thus far, considerable research has been focused on classifying a lesion as benign or malignant. However, there is a requirement for quick depth estimation of a lesion for the accurate clinical staging of the lesion. The lesion could be malignant and quickly grow beneath the skin. While biopsy slides provide clear information on lesion depth, it is an emerging domain to find quick and noninvasive methods to estimate depth, particularly based on 2D images.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This study proposes a novel methodology for the depth estimation and visualization of skin lesions. Current diagnostic methods are approximate in determining how much a lesion may have proliferated within the skin. Using color gradients and depth maps, this method will give us a definite estimate and visualization procedure for lesions and other skin issues. We aim to generate 3D holograms of the lesion depth such that dermatologists can better diagnose melanoma.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We started by performing classification using a convolutional neural network (CNN), followed by using explainable artificial intelligence to localize the image features responsible for the CNN output. We used the gradient class activation map approach to perform localization of the lesion from the rest of the image. We applied computer graphics for depth estimation and developing the 3D structure of the lesion. We used the depth from defocus method for depth estimation from single images and Gabor filters for volumetric representation of the depth map. Our novel method, called red spot analysis, measures the degree of infection based on how a conical hologram is constructed. We collaborated with a dermatologist to analyze the 3D hologram output and received feedback on how this method can be introduced to clinical implementation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The neural model plus the explainable artificial intelligence algorithm achieved an accuracy of 86% in classifying the lesions correctly as benign or malignant. For the entire pipeline, we mapped the benign and malignant cases to their conical representations. We received exceedingly positive feedback while pitching this idea at the King Edward Memorial Institute in India. Dermatologists considered this a potentially useful tool in the depth estimation of lesions. We received a number of ideas for evaluating the technique before it can be introduced to the clinical scene.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;When we map the CNN outputs (benign or malignant) to the corresponding hologram, we observe that a malignant lesion has a higher concentration of red spots (infection) in the upper and deeper portions of the skin, and that the malignant cases have deeper conical sections when compared with the benign cases. This proves that the qualitative results map with the initial classification performed by the neural model. The positive feedback provided by the dermatologist suggests that th","PeriodicalId":73553,"journal":{"name":"JMIR dermatology","volume":"7 ","pages":"e59839"},"PeriodicalIF":0.0,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11694055/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142856898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving Affordability in Dermatology: Cost Savings in Mark Cuban Cost Plus Drug Company Versus GoodRx. 提高皮肤科的可负担性:Mark Cuban Cost Plus Drug Company 与 GoodRx 的成本节约。
Q3 Medicine Pub Date : 2024-12-13 DOI: 10.2196/64300
Christopher G Youn, Joo Yeon Kim, Vivian B Yang, Gordon H Bae

Unlabelled: This observational cost analysis was conducted to assess the efficacy of the Mark Cuban Cost Plus Drug Company (CostPlus) relative to GoodRx and found that CostPlus has significant potential to improve the financial burden of prescription medications within dermatology.

{"title":"Improving Affordability in Dermatology: Cost Savings in Mark Cuban Cost Plus Drug Company Versus GoodRx.","authors":"Christopher G Youn, Joo Yeon Kim, Vivian B Yang, Gordon H Bae","doi":"10.2196/64300","DOIUrl":"10.2196/64300","url":null,"abstract":"<p><strong>Unlabelled: </strong>This observational cost analysis was conducted to assess the efficacy of the Mark Cuban Cost Plus Drug Company (CostPlus) relative to GoodRx and found that CostPlus has significant potential to improve the financial burden of prescription medications within dermatology.</p>","PeriodicalId":73553,"journal":{"name":"JMIR dermatology","volume":"7 ","pages":"e64300"},"PeriodicalIF":0.0,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11661688/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142823023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dermatology in Student-Run Clinics in the United States: Scoping Review. 美国学生开设诊所的皮肤科:范围审查。
Q3 Medicine Pub Date : 2024-12-13 DOI: 10.2196/59368
Samir Kamat, Aneesh Agarwal, Leore Lavin, Hannah Verma, Lily Martin, Jules B Lipoff

Background: Student-run clinics (SRCs) for dermatology hold potential to significantly advance skin-related health equity, and a comprehensive analysis of these clinics may inform strategies for optimizing program effectiveness.

Objective: We aimed to perform a scoping review of the literature about dermatology SRCs across the United States.

Methods: We conducted systematic literature searches of Ovid MEDLINE, Ovid Embase, and Scopus on March 1, 2023, and June 19, 2024. No date, language, or paper-type restrictions were included in the search strategy. A total of 229 references were uploaded to Covidence for screening by 2 independent reviewers (SK and LL), and 23 full-text documents were assessed for eligibility. After an additional 8 documents were identified through a gray literature search, a total of 31 studies were included in the final analysis. Inclusion criteria were as follows: (1) studies set in an SRC, which was operationally led by medical students and could render condition-relevant treatments to patients, with dermatology care; (2) published in English; (3) within the United States; (4) included characterization of any of the following: logistics, care, patients, or design; and (5) included all study or document types, including gray literature that was not peer reviewed (eg, conference abstracts, preprints, and letters to the editor). Exclusion criteria were (1) papers not published in English and (2) those with duplicated data or that were limited in scope or not generalizable. Data were extracted qualitatively using Microsoft Excel to categorize the studies by several domains, including clinic location, demographics, services offered, and barriers to care.

Results: There are at least 19 dermatology SRCs across the United States. The most common conditions encountered included atopic dermatitis; acne; fungal infections; benign nevi; psoriasis; and neoplasms, such as basal cell carcinoma, squamous cell carcinoma, and melanoma. Key facilitators for the clinics included faculty oversight, attending physician participation for biopsy histopathology, and dedicated program coordinators. Major barriers included lack of follow-up, medication nonadherence, and patient no-shows.

Conclusions: Dermatology SRCs serve a diverse patient population, many of whom are underrepresented in traditional dermatology settings. This scoping review provides insights to help build stronger program foundations that better address community dermatologic health needs.

{"title":"Dermatology in Student-Run Clinics in the United States: Scoping Review.","authors":"Samir Kamat, Aneesh Agarwal, Leore Lavin, Hannah Verma, Lily Martin, Jules B Lipoff","doi":"10.2196/59368","DOIUrl":"10.2196/59368","url":null,"abstract":"<p><strong>Background: </strong>Student-run clinics (SRCs) for dermatology hold potential to significantly advance skin-related health equity, and a comprehensive analysis of these clinics may inform strategies for optimizing program effectiveness.</p><p><strong>Objective: </strong>We aimed to perform a scoping review of the literature about dermatology SRCs across the United States.</p><p><strong>Methods: </strong>We conducted systematic literature searches of Ovid MEDLINE, Ovid Embase, and Scopus on March 1, 2023, and June 19, 2024. No date, language, or paper-type restrictions were included in the search strategy. A total of 229 references were uploaded to Covidence for screening by 2 independent reviewers (SK and LL), and 23 full-text documents were assessed for eligibility. After an additional 8 documents were identified through a gray literature search, a total of 31 studies were included in the final analysis. Inclusion criteria were as follows: (1) studies set in an SRC, which was operationally led by medical students and could render condition-relevant treatments to patients, with dermatology care; (2) published in English; (3) within the United States; (4) included characterization of any of the following: logistics, care, patients, or design; and (5) included all study or document types, including gray literature that was not peer reviewed (eg, conference abstracts, preprints, and letters to the editor). Exclusion criteria were (1) papers not published in English and (2) those with duplicated data or that were limited in scope or not generalizable. Data were extracted qualitatively using Microsoft Excel to categorize the studies by several domains, including clinic location, demographics, services offered, and barriers to care.</p><p><strong>Results: </strong>There are at least 19 dermatology SRCs across the United States. The most common conditions encountered included atopic dermatitis; acne; fungal infections; benign nevi; psoriasis; and neoplasms, such as basal cell carcinoma, squamous cell carcinoma, and melanoma. Key facilitators for the clinics included faculty oversight, attending physician participation for biopsy histopathology, and dedicated program coordinators. Major barriers included lack of follow-up, medication nonadherence, and patient no-shows.</p><p><strong>Conclusions: </strong>Dermatology SRCs serve a diverse patient population, many of whom are underrepresented in traditional dermatology settings. This scoping review provides insights to help build stronger program foundations that better address community dermatologic health needs.</p>","PeriodicalId":73553,"journal":{"name":"JMIR dermatology","volume":"7 ","pages":"e59368"},"PeriodicalIF":0.0,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11661691/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142823010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dermatologic Data From the Global Burden of Disease Study 2019 and the PatientsLikeMe Online Support Community: Comparative Analysis.
Q3 Medicine Pub Date : 2024-12-11 DOI: 10.2196/50449
Mindy D Szeto, Lina Alhanshali, Chandler W Rundle, Madeline Adelman, Michelle Hook Sobotka, Emily Woolhiser, Jieying Wu, Colby L Presley, Jalal Maghfour, John Meisenheimer, Jaclyn B Anderson, Robert P Dellavalle

Unlabelled: The Global Burden of Disease (GBD) study aims to characterize the worldwide prevalence and morbidity of major diseases, while PatientsLikeMe (PLM) is an online community providing patient-generated insights into lived experiences; for dermatologic conditions, quantitative comparisons of GBD and PLM data revealed expected demographic differences but also notable correlations, highlighting their potential as complementary data sources elucidating unmet patient needs and priorities.

{"title":"Dermatologic Data From the Global Burden of Disease Study 2019 and the PatientsLikeMe Online Support Community: Comparative Analysis.","authors":"Mindy D Szeto, Lina Alhanshali, Chandler W Rundle, Madeline Adelman, Michelle Hook Sobotka, Emily Woolhiser, Jieying Wu, Colby L Presley, Jalal Maghfour, John Meisenheimer, Jaclyn B Anderson, Robert P Dellavalle","doi":"10.2196/50449","DOIUrl":"10.2196/50449","url":null,"abstract":"<p><strong>Unlabelled: </strong>The Global Burden of Disease (GBD) study aims to characterize the worldwide prevalence and morbidity of major diseases, while PatientsLikeMe (PLM) is an online community providing patient-generated insights into lived experiences; for dermatologic conditions, quantitative comparisons of GBD and PLM data revealed expected demographic differences but also notable correlations, highlighting their potential as complementary data sources elucidating unmet patient needs and priorities.</p>","PeriodicalId":73553,"journal":{"name":"JMIR dermatology","volume":"7 ","pages":"e50449"},"PeriodicalIF":0.0,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11655042/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142815143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lichen Planus Pigmentosus and Vitiligo in a 61-Year-Old Filipino Man: Case Report.
Q3 Medicine Pub Date : 2024-11-29 DOI: 10.2196/50401
Maria Isabel Belizario, Julius Garcia Gatmaitan, Johannes Dayrit

Unlabelled: Pigmentary disorders have been implicated in causing psychosocial turmoil in patients as they can cause some degree of cosmetic disfigurement. Lichen planus pigmentosus (LPP) presents as ashy, dermatosis-like eruptions on sun-exposed areas, particularly on the head, neck, and earlobes. On the other hand, vitiligo is a chronic disorder that appears as depigmented patches on the skin. A 61-year-old man with Fitzpatrick skin phototype IV presented to us initially with LPP but eventually also developed vitiligo. The patient was treated with low-dose oral isotretinoin for LPP and topical tacrolimus 0.1% ointment for both LPP and vitiligo with a good clinical outcome. One case of segmental vitiligo and zosteriform LPP, affecting a 22-year-old Indian woman, has been previously reported in the English-language literature. An autoimmune etiology that causes melanocytorrhagy may be a plausible hypothesis for the coexistence of these 2 conditions.

{"title":"Lichen Planus Pigmentosus and Vitiligo in a 61-Year-Old Filipino Man: Case Report.","authors":"Maria Isabel Belizario, Julius Garcia Gatmaitan, Johannes Dayrit","doi":"10.2196/50401","DOIUrl":"10.2196/50401","url":null,"abstract":"<p><strong>Unlabelled: </strong>Pigmentary disorders have been implicated in causing psychosocial turmoil in patients as they can cause some degree of cosmetic disfigurement. Lichen planus pigmentosus (LPP) presents as ashy, dermatosis-like eruptions on sun-exposed areas, particularly on the head, neck, and earlobes. On the other hand, vitiligo is a chronic disorder that appears as depigmented patches on the skin. A 61-year-old man with Fitzpatrick skin phototype IV presented to us initially with LPP but eventually also developed vitiligo. The patient was treated with low-dose oral isotretinoin for LPP and topical tacrolimus 0.1% ointment for both LPP and vitiligo with a good clinical outcome. One case of segmental vitiligo and zosteriform LPP, affecting a 22-year-old Indian woman, has been previously reported in the English-language literature. An autoimmune etiology that causes melanocytorrhagy may be a plausible hypothesis for the coexistence of these 2 conditions.</p>","PeriodicalId":73553,"journal":{"name":"JMIR dermatology","volume":"7 ","pages":"e50401"},"PeriodicalIF":0.0,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11623345/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142756035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of ChatGPT in Educating Patients and Clinicians About Skin Toxicities Associated With Cancer Treatment. ChatGPT 在教育患者和临床医生了解癌症治疗相关皮肤毒性方面的功效。
Q3 Medicine Pub Date : 2024-11-20 DOI: 10.2196/54919
Annie Chang, Jade Young, Andrew Para, Angela Lamb, Nicholas Gulati

Unlabelled: This study investigates the application of ChatGPT, an artificial intelligence tool, in providing information on skin toxicities associated with cancer treatments, highlighting that while ChatGPT can serve as a valuable resource for clinicians, its use for patient education requires careful consideration due to the complex nature of the information provided.

无标签:本研究调查了人工智能工具 ChatGPT 在提供与癌症治疗相关的皮肤毒性信息方面的应用,强调虽然 ChatGPT 可作为临床医生的宝贵资源,但由于所提供信息的复杂性,将其用于患者教育需要慎重考虑。
{"title":"Efficacy of ChatGPT in Educating Patients and Clinicians About Skin Toxicities Associated With Cancer Treatment.","authors":"Annie Chang, Jade Young, Andrew Para, Angela Lamb, Nicholas Gulati","doi":"10.2196/54919","DOIUrl":"10.2196/54919","url":null,"abstract":"<p><strong>Unlabelled: </strong>This study investigates the application of ChatGPT, an artificial intelligence tool, in providing information on skin toxicities associated with cancer treatments, highlighting that while ChatGPT can serve as a valuable resource for clinicians, its use for patient education requires careful consideration due to the complex nature of the information provided.</p>","PeriodicalId":73553,"journal":{"name":"JMIR dermatology","volume":"7 ","pages":"e54919"},"PeriodicalIF":0.0,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11600653/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142677969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How Dermatologists Can Aid Nondermatologic Professionals Using the Figure 1 App: Case Analysis.
Q3 Medicine Pub Date : 2024-11-13 DOI: 10.2196/60500
Alexis Coican, Nathaniel A Marroquin, Alexa Carboni, Sara Holt, Morgan Zueger

Unlabelled: We found that third-party apps such as Figure 1 were used predominantly by nondermatologist medical personnel for collaboration in medical decision-making related to dermatologic conditions conducted with other health care providers. This finding calls attention to the need for more readily available resources for nondermatologist health care providers encountering patients with skin-related conditions, with the added benefits of trained dermatologists being allies on such medical app platforms, and the platform allowing for recognition of instances when additional consultation or referral to trained dermatologists for more complex cases is appropriate.

{"title":"How Dermatologists Can Aid Nondermatologic Professionals Using the <i>Figure 1</i> App: Case Analysis.","authors":"Alexis Coican, Nathaniel A Marroquin, Alexa Carboni, Sara Holt, Morgan Zueger","doi":"10.2196/60500","DOIUrl":"https://doi.org/10.2196/60500","url":null,"abstract":"<p><strong>Unlabelled: </strong>We found that third-party apps such as Figure 1 were used predominantly by nondermatologist medical personnel for collaboration in medical decision-making related to dermatologic conditions conducted with other health care providers. This finding calls attention to the need for more readily available resources for nondermatologist health care providers encountering patients with skin-related conditions, with the added benefits of trained dermatologists being allies on such medical app platforms, and the platform allowing for recognition of instances when additional consultation or referral to trained dermatologists for more complex cases is appropriate.</p>","PeriodicalId":73553,"journal":{"name":"JMIR dermatology","volume":"7 ","pages":"e60500"},"PeriodicalIF":0.0,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11587997/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142775302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cutaneous Adverse Effects From Diabetes Devices in Pediatric Patients With Type 1 Diabetes Mellitus: Systematic Review.
Q3 Medicine Pub Date : 2024-11-07 DOI: 10.2196/59824
Alicia Podwojniak, Joseph Flemming, Isabella J Tan, Hira Ghani, Zachary Neubauer, Anne Jones

Background: Continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusions (CSIIs) are the current standard treatment devices for type 1 diabetes (T1D) management. With a high prevalence of T1D beginning in pediatrics and carrying into adulthood, insufficient glycemic control leads to poor patient outcomes. Dermatologic complications such as contact dermatitis, lipodystrophies, and inflammatory lesions are among those associated with CGM and CSII, which reduce glycemic control and patient compliance.

Objective: This systematic review aims to explore the current literature surrounding dermatologic complications of CGM and CSII as well as the impact on patient outcomes.

Methods: A systematic review of the literature was carried out using PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 guidelines using 5 online databases. Included articles were those containing primary data relevant to human participants and adverse reactions to CGM and CSII devices in pediatric populations, of which greater than 50% of the sample size were aged 0-21 years. Qualitative analysis was chosen due to the heterogeneity of outcomes.

Results: Following the application of exclusion criteria, 25 studies were analyzed and discussed. An additional 5 studies were identified after the initial search and inclusion. The most common complication covered is contact dermatitis, with 13 identified studies. Further, 7 studies concerned lipodystrophies, 5 covered nonspecific cutaneous changes, 3 covered unique cutaneous findings such as granulomatous reactions and panniculitis, and 2 discussed user acceptability.

Conclusions: The dermatologic complications of CGM and CSII pose a potential risk to long-term glycemic control in T1D, especially in young patients where skin lesions can lead to discontinuation. Increased manufacturer transparency is critical and further studies are needed to expand upon the current preventative measures such as device site rotation and steroid creams, which lack consistent effectiveness.

{"title":"Cutaneous Adverse Effects From Diabetes Devices in Pediatric Patients With Type 1 Diabetes Mellitus: Systematic Review.","authors":"Alicia Podwojniak, Joseph Flemming, Isabella J Tan, Hira Ghani, Zachary Neubauer, Anne Jones","doi":"10.2196/59824","DOIUrl":"https://doi.org/10.2196/59824","url":null,"abstract":"<p><strong>Background: </strong>Continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusions (CSIIs) are the current standard treatment devices for type 1 diabetes (T1D) management. With a high prevalence of T1D beginning in pediatrics and carrying into adulthood, insufficient glycemic control leads to poor patient outcomes. Dermatologic complications such as contact dermatitis, lipodystrophies, and inflammatory lesions are among those associated with CGM and CSII, which reduce glycemic control and patient compliance.</p><p><strong>Objective: </strong>This systematic review aims to explore the current literature surrounding dermatologic complications of CGM and CSII as well as the impact on patient outcomes.</p><p><strong>Methods: </strong>A systematic review of the literature was carried out using PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 guidelines using 5 online databases. Included articles were those containing primary data relevant to human participants and adverse reactions to CGM and CSII devices in pediatric populations, of which greater than 50% of the sample size were aged 0-21 years. Qualitative analysis was chosen due to the heterogeneity of outcomes.</p><p><strong>Results: </strong>Following the application of exclusion criteria, 25 studies were analyzed and discussed. An additional 5 studies were identified after the initial search and inclusion. The most common complication covered is contact dermatitis, with 13 identified studies. Further, 7 studies concerned lipodystrophies, 5 covered nonspecific cutaneous changes, 3 covered unique cutaneous findings such as granulomatous reactions and panniculitis, and 2 discussed user acceptability.</p><p><strong>Conclusions: </strong>The dermatologic complications of CGM and CSII pose a potential risk to long-term glycemic control in T1D, especially in young patients where skin lesions can lead to discontinuation. Increased manufacturer transparency is critical and further studies are needed to expand upon the current preventative measures such as device site rotation and steroid creams, which lack consistent effectiveness.</p>","PeriodicalId":73553,"journal":{"name":"JMIR dermatology","volume":"7 ","pages":"e59824"},"PeriodicalIF":0.0,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11587996/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142775366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
US Public Interest in Merkel Cell Carcinoma Following Jimmy Buffett's Death and Implications for Continued Health Advocacy: Infodemiology Study of Google Trends. 吉米-巴菲特(Jimmy Buffett)去世后美国公众对梅克尔细胞癌的兴趣及其对持续健康宣传的影响:谷歌趋势信息学研究。
Q3 Medicine Pub Date : 2024-10-31 DOI: 10.2196/60282
Macy Haight, Hayden R Jacobs, Sarah K Boltey, Kelly A Murray, Micah Hartwell

Unlabelled: Through Jimmy Buffett's unfortunate battle with lymphoma originating from Merkel cell carcinoma and subsequent media coverage of his death, public interest in skin cancer, Merkel cell carcinoma, and the health effects of sunlight exposure increased, as evidenced by our results.

无标签:吉米-巴菲特不幸罹患梅克尔细胞癌引发的淋巴瘤,随后媒体对他的死进行了报道,公众对皮肤癌、梅克尔细胞癌以及阳光照射对健康的影响的兴趣也随之增加,我们的研究结果就是明证。
{"title":"US Public Interest in Merkel Cell Carcinoma Following Jimmy Buffett's Death and Implications for Continued Health Advocacy: Infodemiology Study of Google Trends.","authors":"Macy Haight, Hayden R Jacobs, Sarah K Boltey, Kelly A Murray, Micah Hartwell","doi":"10.2196/60282","DOIUrl":"10.2196/60282","url":null,"abstract":"<p><strong>Unlabelled: </strong>Through Jimmy Buffett's unfortunate battle with lymphoma originating from Merkel cell carcinoma and subsequent media coverage of his death, public interest in skin cancer, Merkel cell carcinoma, and the health effects of sunlight exposure increased, as evidenced by our results.</p>","PeriodicalId":73553,"journal":{"name":"JMIR dermatology","volume":"7 ","pages":"e60282"},"PeriodicalIF":0.0,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11542905/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142559645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JMIR dermatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1